Platte River Capital’s Edwards Lifesciences EW Stock Holding History

Platte River Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-33,000	Closed	-$783K	–	123
2015 Q2	$783K	Sell	33,000 -6,000	-15%	-$135K	0.39%	75
2015 Q1	$926K	Sell	39,000 -6,000	-13%	-$135K	0.42%	72
2014 Q4	$955K	Buy	45,000 +6,000	+15%	+$121K	0.35%	85
2014 Q3	$664K	Buy	39,000 +15,000	+63%	+$237K	0.17%	129
2014 Q2	$343K	Buy	+24,000	New	+$325K	0.05%	178

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Platte River Capital's EW Position: Q3 2015 in Review

Platte River Capital sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 33,000 shares — an estimated $783K sold.

Platte River Capital first reported a position in EW in Q2 2014 and held it in 5 quarters. The position peaked at $955K in Q4 2014. 568 funds tracked by Wall St. Rank hold EW as of Q3 2015.

Platte River Capital reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
Platte River Capital sold 33,000 Edwards Lifesciences shares in Q3 2015, an estimated $783K.
Platte River Capital first reported a position in Edwards Lifesciences in Q2 2014 and held it in 5 quarters.
Platte River Capital's Edwards Lifesciences position peaked at $955K in Q4 2014.
568 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.